PMID- 17717122 OWN - NLM STAT- MEDLINE DCOM- 20080108 LR - 20130926 IS - 8750-7587 (Print) IS - 0161-7567 (Linking) VI - 103 IP - 5 DP - 2007 Nov TI - Vascular endothelial sampling and analysis of gene transcripts: a new quantitative approach to monitor vascular inflammation. PG - 1873-8 AB - BACKGROUND: Limited access to endothelial tissue is a major constraint when investigating the cellular mechanisms of vascular inflammation in patients with cardiovascular and metabolic diseases. We introduce venous endothelial sampling coupled to quantitative analysis of gene transcripts by real-time PCR, as a novel approach to study endothelial gene expression in human subjects. METHODS: Endothelial cells were collected from a superficial forearm vein using five guide wires sequentially inserted through a 20-gauge angiocatheter in seven patients with history of cardiovascular events related to advanced vascular disease and in 17 healthy subjects. Endothelial cells were purified using magnetic beads coated with endothelial specific antibodies. Endothelial mRNA was amplified using RiboAmp HS RNA Amplification kit (Molecular Devices, Sunnyvale, CA). Amplified RNA was analyzed by real-time PCR. RESULTS: Linearity of RNA amplification was validated by real-time PCR using RNA from 1,000 human umbilical endothelial cells (HUVECs) before and after amplification. In human subjects, vascular disease was associated with significant induction of proatherosclerotic genes: early growth response gene product (Egr-1) and monocyte chemoattractant protein-1 (MCP-1). CONCLUSION: Venous endothelial sampling coupled to real-time PCR analysis is a minimally invasive, safe, and reliable technique to monitor vascular inflammation in human subjects. Expression of genes implicated in the atherosclerotic process is increased in the venous endothelium of patients with arterial vascular disease. Venous endothelial sampling and quantitative analysis of gene expression may help develop new vascular-targeted biomarkers to identify and track the impact of disease states and therapeutic interventions in vascular diseases. FAU - Onat, Duygu AU - Onat D AD - Department of Medicine, Columbia Univ., New York, NY, USA. FAU - Jelic, Sanja AU - Jelic S FAU - Schmidt, Ann Marie AU - Schmidt AM FAU - Pile-Spellman, John AU - Pile-Spellman J FAU - Homma, Shunichi AU - Homma S FAU - Padeletti, Margherita AU - Padeletti M FAU - Jin, Zhezhen AU - Jin Z FAU - Le Jemtel, Thierry H AU - Le Jemtel TH FAU - Colombo, Paolo C AU - Colombo PC FAU - Feng, Lei AU - Feng L LA - eng GR - K23-HL-72758/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070823 PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Early Growth Response Protein 1) RN - 0 (RNA, Messenger) SB - IM MH - Aged MH - Cardiovascular Diseases/*genetics/metabolism MH - Case-Control Studies MH - *Cell Separation MH - Cells, Cultured MH - Chemokine CCL2/analysis/genetics MH - Early Growth Response Protein 1/analysis/genetics MH - Endothelium, Vascular/*chemistry MH - Female MH - Gene Expression Profiling/*methods MH - Humans MH - Inflammation/*genetics/metabolism MH - Male MH - Middle Aged MH - *Polymerase Chain Reaction MH - RNA, Messenger/*analysis MH - Reproducibility of Results MH - *Transcription, Genetic EDAT- 2007/08/25 09:00 MHDA- 2008/01/09 09:00 CRDT- 2007/08/25 09:00 PHST- 2007/08/25 09:00 [pubmed] PHST- 2008/01/09 09:00 [medline] PHST- 2007/08/25 09:00 [entrez] AID - 00367.2007 [pii] AID - 10.1152/japplphysiol.00367.2007 [doi] PST - ppublish SO - J Appl Physiol (1985). 2007 Nov;103(5):1873-8. doi: 10.1152/japplphysiol.00367.2007. Epub 2007 Aug 23.